Post-transcriptional regulation of myelin formation

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1779, Issue 8, 2008, Pages 486-494

  Zearfoss, N Ruth ^a   Farley, Brian M ^a   Ryder, Sean P ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Development; Myelin; Oligodendroctye; Post transcriptional regulation; RNA binding protein; Specificity

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MUSASHI1 PROTEIN; MYELIN; QUAKING PROTEIN; RNA BINDING PROTEIN;

BRAIN; CELL DIFFERENTIATION; CELL TYPE; GENE EXPRESSION; HUMAN; MAMMAL; MOLECULAR DYNAMICS; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROCESSING; REVIEW;

ANIMALS; AXONS; BRAIN; FRAGILE X MENTAL RETARDATION PROTEIN; GENE EXPRESSION REGULATION; MICE; MICE, QUAKING; MYELIN SHEATH; OLIGODENDROGLIA; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 49549096679     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2008.06.003     Document Type: Review

References (107)

1. Griffiths I., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., Schneider A., Zimmermann F., McCulloch M., Nadon N., and Nave K.A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280 (1998) 1610-1613
2. Lappe-Siefke C., Goebbels S., Gravel M., Nicksch E., Lee J., Braun P.E., Griffiths I.R., and Nave K.A. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 33 (2003) 366-374
3. Schwab M.E., and Caroni P. Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J. Neurosci. 8 (1988) 2381-2393
4. McGee A.W., Yang Y., Fischer Q.S., Daw N.W., and Strittmatter S.M. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science 309 (2005) 2222-2226
5. Arroyo E.J., and Scherer S.S. On the molecular architecture of myelinated fibers. Histochem. Cell. Biol. 113 (2000) 1-18
6. Rogister B., Ben-Hur T., and Dubois-Dalcq M. From neural stem cells to myelinating oligodendrocytes. Mol. Cell Neurosci. 14 (1999) 287-300
7. Nicolay D.J., Doucette J.R., and Nazarali A.J. Transcriptional control of oligodendrogenesis. Glia 55 (2007) 1287-1299
8. Simons M., and Trotter J. Wrapping it up: the cell biology of myelination. Curr. Opin. Neurobiol. 17 (2007) 533-540
9. Casaccia-Bonnefil P., and Liu A. Relationship between cell cycle molecules and onset of oligodendrocyte differentiation. J. Neurosci. Res. 72 (2003) 1-11
10. Thomas M.G., Martinez Tosar L.J., Loschi M., Pasquini J.M., Correale J., Kindler S., and Boccaccio G.L. Staufen recruitment into stress granules does not affect early mRNA transport in oligodendrocytes. Mol. Biol. Cell 16 (2005) 405-420
11. Khalili K., Del Valle L., Muralidharan V., Gault W.J., Darbinian N., Otte J., Meier E., Johnson E.M., Daniel D.C., Kinoshita Y., Amini S., and Gordon J. Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol. Cell Biol. 23 (2003) 6857-6875
12. Dobson N.R., Zhou Y.X., Flint N.C., and Armstrong R.C. Musashi1 RNA-binding protein regulates oligodendrocyte lineage cell differentiation and survival. Glia 56 (2008) 318-330
13. Wang H., Ku L., Osterhout D.J., Li W., Ahmadian A., Liang Z., and Feng Y. Developmentally-programmed FMRP expression in oligodendrocytes: a potential role of FMRP in regulating translation in oligodendroglia progenitors. Hum. Mol. Genet. 13 (2004) 79-89
14. Ebersole T.A., Chen Q., Justice M.J., and Artzt K. The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat. Genet. 12 (1996) 260-265
15. Carson J.H., Gao Y., Tatavarty V., Levin M.K., Korza G., Francone V.P., Kosturko L.D., Maggipinto M.J., and Barbarese E. Multiplexed RNA trafficking in oligodendrocytes and neurons. Biochim. Biophys. Acta (2008)
16. Sidman R.L., Dickie M.M., and Appel S.H. Mutant mice (Quaking and Jimpy) with deficient myelination in the central nervous system. Science 144 (1964) 309-311
17. Suter U., Welcher A.A., Ozcelik T., Snipes G.J., Kosaras B., Francke U., Billings-Gagliardi S., Sidman R.L., and Shooter E.M. Trembler mouse carries a point mutation in a myelin gene. Nature 356 (1992) 241-244
18. Dautigny A., Mattei M.G., Morello D., Alliel P.M., Pham-Dinh D., Amar L., Arnaud D., Simon D., Mattei J.F., Guenet J.L., et al. The structural gene coding for myelin-associated proteolipid protein is mutated in jimpy mice. Nature 321 (1986) 867-869
19. Wolf M.K., and Billings-Gagliardi S. CNS hypomyelinated mutant mice (jimpy, shiverer, quaking): in vitro evidence for primary oligodendrocyte defects. Adv. Exp. Med. Biol. 181 (1984) 115-133
20. Barbarese E., Nielson M.L., and Carson J.H. The effect of the shiverer mutation on myelin basic protein expression in homozygous and heterozygous mouse brain. J. Neurochem. 40 (1983) 1680-1686
21. Molineaux S.M., Engh H., de Ferra F., Hudson L., and Lazzarini R.A. Recombination within the myelin basic protein gene created the dysmyelinating shiverer mouse mutation. Proc. Natl. Acad. Sci. U S A 83 (1986) 7542-7546
22. Ebersole T., Rho O., and Artzt K. The proximal end of mouse chromosome 17: new molecular markers identify a deletion associated with quakingviable. Genetics 131 (1992) 183-190
23. Lockhart P.J., O'Farrell C.A., and Farrer M.J. It's a double knock-out! The quaking mouse is a spontaneous deletion of parkin and parkin co-regulated gene (PACRG). Mov. Disord. 19 (2004) 101-104
24. Lorenzetti D., Antalffy B., Vogel H., Noveroske J., Armstrong D., and Justice M. The neurological mutant quaking(viable) is Parkin deficient. Mamm. Genome 15 (2004) 210-217
25. Hardy R.J., Loushin C.L., Friedrich Jr. V.L., Chen Q., Ebersole T.A., Lazzarini R.A., and Artzt K. Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice. J. Neurosci. 16 (1996) 7941-7949
26. Noveroske J.K., Hardy R., Dapper J.D., Vogel H., and Justice M.J. A new ENU-induced allele of mouse quaking causes severe CNS dysmyelination. Mamm. Genome 16 (2005) 672-682
27. Justice M.J., and Bode V.C. Three ENU-induced alleles of the murine quaking locus are recessive embryonic lethal mutations. Genet. Res. 51 (1988) 95-102
28. Zhao L., Tian D., Xia M., Macklin W.B., and Feng Y. Rescuing qkV dysmyelination by a single isoform of the selective RNA-binding protein QKI. J. Neurosci. 26 (2006) 11278-11286
29. Ryder S.P., Frater L.A., Abramovitz D.L., Goodwin E.B., and Williamson J.R. RNA target specificity of the STAR/GSG domain post-transcriptional regulatory protein GLD-1. Nat. Struct. Mol. Biol. 11 (2004) 20-28
30. Baehrecke E.H. who encodes a KH RNA binding protein that functions in muscle development. Development 124 (1997) 1323-1332
31. Zaffran S., Astier M., Gratecos D., and Semeriva M. The held out wings (how) Drosophila gene encodes a putative RNA-binding protein involved in the control of muscular and cardiac activity. Development 124 (1997) 2087-2098
32. Maguire M.L., Guler-Gane G., Nietlispach D., Raine A.R., Zorn A.M., Standart N., and Broadhurst R.W. Solution structure and backbone dynamics of the KH-QUA2 region of the Xenopus STAR/GSG quaking protein. J. Mol. Biol. 348 (2005) 265-279
33. Chen T., and Richard S. Structure-function analysis of Qk1: a lethal point mutation in mouse quaking prevents homodimerization. Mol. Cell Biol. 18 (1998) 4863-4871
34. Ryder S.P., and Williamson J.R. Specificity of the STAR/GSG domain protein Qk1: implications for the regulation of myelination. Rna 10 (2004) 1449-1458
35. Kondo T., Furuta T., Mitsunaga K., Ebersole T.A., Shichiri M., Wu J., Artzt K., Yamamura K., and Abe K. Genomic organization and expression analysis of the mouse qkI locus. Mamm. Genome 10 (1999) 662-669
36. Larocque D., Pilotte J., Chen T., Cloutier F., Massie B., Pedraza L., Couture R., Lasko P., Almazan G., and Richard S. Nuclear retention of MBP mRNAs in the quaking viable mice. Neuron 36 (2002) 815-829
37. Genoud S., Lappe-Siefke C., Goebbels S., Radtke F., Aguet M., Scherer S.S., Suter U., Nave K.A., and Mantei N. Notch1 control of oligodendrocyte differentiation in the spinal cord. J. Cell Biol. 158 (2002) 709-718
38. Khattari Z., Ruschel Y., Wen H.Z., Fischer A., and Fischer T.M. Compactification of a myelin mimetic Langmuir monolayer upon adsorption and unfolding of myelin basic protein. J. Phys. Chem. B 109 (2005) 3402-3407
39. Cristofolini L., Fontana M.P., Serra F., Fasano A., Riccio P., and Konovalov O. Microstructural analysis of the effects of incorporation of myelin basic protein in phospholipid layers. Eur. Biophys. J. 34 (2005) 1041-1048
40. Rispoli P., Carzino R., Svaldo-Lanero T., Relini A., Cavalleri O., Fasano A., Liuzzi G.M., Carlone G., Riccio P., Gliozzi A., and Rolandi R. A thermodynamic and structural study of myelin basic protein in lipid membrane models. Biophys. J. 93 (2007) 1999-2010
41. Roach A., Takahashi N., Pravtcheva D., Ruddle F., and Hood L. Chromosomal mapping of mouse myelin basic protein gene and structure and transcription of the partially deleted gene in shiverer mutant mice. Cell 42 (1985) 149-155
42. Bird T.D., Farrell D.F., and Sumi S.M. Brain lipid composition of the shiverer mouse: (genetic defect in myelin development). J. Neurochem. 31 (1978) 387-391
43. Rosenbluth J. Central myelin in the mouse mutant shiverer. J. Comp. Neurol. 194 (1980) 639-648
44. Rosenbluth J. Peripheral myelin in the mouse mutant Shiverer. J. Comp. Neurol. 193 (1980) 729-739
45. Kirschner D.A., and Ganser A.L. Compact myelin exists in the absence of basic protein in the shiverer mutant mouse. Nature 283 (1980) 207-210
46. Li Z., Zhang Y., Li D., and Feng Y. Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J. Neurosci. 20 (2000) 4944-4953
47. Zhang Y., Lu Z., Ku L., Chen Y., Wang H., and Feng Y. Tyrosine phosphorylation of QKI mediates developmental signals to regulate mRNA metabolism. Embo J. 22 (2003) 1801-1810
48. Wu J.I., Reed R.B., Grabowski P.J., and Artzt K. Function of quaking in myelination: regulation of alternative splicing. Proc. Natl. Acad. Sci. U S A 99 (2002) 4233-4238
49. Sporkel O., Uschkureit T., Bussow H., and Stoffel W. Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: myelination and development. Glia 37 (2002) 19-30
50. Stecca B., Southwood C.M., Gragerov A., Kelley K.A., Friedrich Jr. V.L., and Gow A. The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin. J. Neurosci. 20 (2000) 4002-4010
51. Li C., Tropak M.B., Gerlai R., Clapoff S., Abramow-Newerly W., Trapp B., Peterson A., and Roder J. Myelination in the absence of myelin-associated glycoprotein. Nature 369 (1994) 747-750
52. Montag D., Giese K.P., Bartsch U., Martini R., Lang Y., Bluthmann H., Karthigasan J., Kirschner D.A., Wintergerst E.S., Nave K.A., et al. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13 (1994) 229-246
53. Erb M., Flueck B., Kern F., Erne B., Steck A.J., and Schaeren-Wiemers N. Unraveling the differential expression of the two isoforms of myelin-associated glycoprotein in a mouse expressing GFP-tagged S-MAG specifically regulated and targeted into the different myelin compartments. Mol. Cell Neurosci. 31 (2006) 613-627
54. de Ferra F., Engh H., Hudson L., Kamholz J., Puckett C., Molineaux S., and Lazzarini R.A. Alternative splicing accounts for the four forms of myelin basic protein. Cell 43 (1985) 721-727
55. Staugaitis S.M., Smith P.R., and Colman D.R. Expression of myelin basic protein isoforms in nonglial cells. J. Cell. Biol. 110 (1990) 1719-1727
56. Allinquant B., Staugaitis S.M., D'Urso D., and Colman D.R. The ectopic expression of myelin basic protein isoforms in Shiverer oligodendrocytes: implications for myelinogenesis. J. Cell Biol. 113 (1991) 393-403
57. Kimura M., Sato M., Akatsuka A., Saito S., Ando K., Yokoyama M., and Katsuki M. Overexpression of a minor component of myelin basic protein isoform (17.2 kDa) can restore myelinogenesis in transgenic shiverer mice. Brain Res. 785 (1998) 245-252
58. Saccomanno L., Loushin C., Jan E., Punkay E., Artzt K., and Goodwin E.B. The STAR protein QKI-6 is a translational repressor. Proc. Natl. Acad. Sci. U S A 96 (1999) 12605-12610
59. Jan E., Motzny C.K., Graves L.E., and Goodwin E.B. The STAR protein, GLD-1, is a translational regulator of sexual identity in Caenorhabditis elegans. Embo J. 18 (1999) 258-269
60. Larocque D., Galarneau A., Liu H.N., Scott M., Almazan G., and Richard S. Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation. Nat. Neurosci. 8 (2005) 27-33
61. Chen Y., Tian D., Ku L., Osterhout D.J., and Feng Y. The selective RNA-binding protein quaking I (QKI) is necessary and sufficient for promoting oligodendroglia differentiation. J. Biol. Chem. 282 (2007) 23553-23560
62. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9 (1995) 1149-1163
63. Casaccia-Bonnefil P., Hardy R.J., Teng K.K., Levine J.M., Koff A., and Chao M.V. Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development 126 (1999) 4027-4037
64. Ainger K., Avossa D., Diana A.S., Barry C., Barbarese E., and Carson J.H. Transport and localization elements in myelin basic protein mRNA. J Cell Biol 138 (1997) 1077-1087
65. Galarneau A., and Richard S. Target RNA motif and target mRNAs of the Quaking STAR protein. Nat. Struct. Mol. Biol. 12 (2005) 691-698
66. Brockman J.M., Singh P., Liu D., Quinlan S., Salisbury J., and Graber J.H. PACdb: PolyA Cleavage Site and 3′-UTR Database. Bioinformatics 21 (2005) 3691-3693
67. Sakakibara S., and Okano H. Expression of neural RNA-binding proteins in the postnatal CNS: implications of their roles in neuronal and glial cell development. J. Neurosci. 17 (1997) 8300-8312
68. Kaneko Y., Sakakibara S., Imai T., Suzuki A., Nakamura Y., Sawamoto K., Ogawa Y., Toyama Y., Miyata T., and Okano H. Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev. Neurosci. 22 (2000) 139-153
69. Sakakibara S., Nakamura Y., Yoshida T., Shibata S., Koike M., Takano H., Ueda S., Uchiyama Y., Noda T., and Okano H. RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation. Proc. Natl. Acad. Sci. U S A 99 (2002) 15194-15199
70. Givogri M.I., Schonmann V., Cole R., De Vellis J., and Bongarzone E.R. Notch1 and Numb genes are inversely expressed as oligodendrocytes differentiate. Dev. Neurosci. 25 (2003) 50-64
71. Battelli C., Nikopoulos G.N., Mitchell J.G., and Verdi J.M. The RNA-binding protein Musashi-1 regulates neural development through the translational repression of p21WAF-1. Mol. Cell Neurosci. 31 (2006) 85-96
72. Imai T., Tokunaga A., Yoshida T., Hashimoto M., Mikoshiba K., Weinmaster G., Nakafuku M., and Okano H. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol. Cell Biol. 21 (2001) 3888-3900
73. Berdnik D., Torok T., Gonzalez-Gaitan M., and Knoblich J.A. The endocytic protein alpha-Adaptin is required for numb-mediated asymmetric cell division in Drosophila. Dev. Cell 3 (2002) 221-231
74. Santolini E., Puri C., Salcini A.E., Gagliani M.C., Pelicci P.G., Tacchetti C., and Di Fiore P.P. Numb is an endocytic protein. J. Cell Biol. 151 (2000) 1345-1352
75. Zhong W., Feder J.N., Jiang M.M., Jan L.Y., and Jan Y.N. Asymmetric localization of a mammalian numb homolog during mouse cortical neurogenesis. Neuron 17 (1996) 43-53
76. Grandbarbe L., Bouissac J., Rand M., Hrabe de Angelis M., Artavanis-Tsakonas S., and Mohier E. Delta-Notch signaling controls the generation of neurons/glia from neural stem cells in a stepwise process. Development 130 (2003) 1391-1402
77. Wang S., Sdrulla A.D., diSibio G., Bush G., Nofziger D., Hicks C., Weinmaster G., and Barres B.A. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21 (1998) 63-75
78. Taylor M.K., Yeager K., and Morrison S.J. Physiological Notch signaling promotes gliogenesis in the developing peripheral and central nervous systems. Development 134 (2007) 2435-2447
79. Givogri M.I., Costa R.M., Schonmann V., Silva A.J., Campagnoni A.T., and Bongarzone E.R. Central nervous system myelination in mice with deficient expression of Notch1 receptor. J. Neurosci. Res. 67 (2002) 309-320
80. Bansal R., Marin-Husstege M., Bryant M., and Casaccia-Bonnefil P. S-phase entry of oligodendrocyte lineage cells is associated with increased levels of p21Cip1. J. Neurosci. Res. 80 (2005) 360-368
81. Bagni C., and Greenough W.T. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat. Rev. Neurosci. 6 (2005) 376-387
82. Pacey L.K., and Doering L.C. Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome. Glia 55 (2007) 1601-1609
83. Meixner A., Haverkamp S., Wassle H., Fuhrer S., Thalhammer J., Kropf N., Bittner R.E., Lassmann H., Wiche G., and Propst F. MAP1B is required for axon guidance and Is involved in the development of the central and peripheral nervous system. J. Cell Biol. 151 (2000) 1169-1178
84. Lu R., Wang H., Liang Z., Ku L., O'Donnell T., Li W., Warren S.T., and Feng Y. The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc. Natl. Acad. Sci. U S A 101 (2004) 15201-15206
85. Brown V., Jin P., Ceman S., Darnell J.C., O'Donnell W.T., Tenenbaum S.A., Jin X., Feng Y., Wilkinson K.D., Keene J.D., Darnell R.B., and Warren S.T. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107 (2001) 477-487
86. Wu H.Y., Dawson M.R., Reynolds R., and Hardy R.J. Expression of QKI proteins and MAP1B identifies actively myelinating oligodendrocytes in adult rat brain. Mol. Cell Neurosci. 17 (2001) 292-302
87. Zhao L., Ku L., Chen Y., Xia M., LoPresti P., and Feng Y. QKI binds MAP1B mRNA and enhances MAP1B expression during oligodendrocyte development. Mol. Biol. Cell 17 (2006) 4179-4186
88. Darnell J.C., Jensen K.B., Jin P., Brown V., Warren S.T., and Darnell R.B. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107 (2001) 489-499
89. Zalfa F., Giorgi M., Primerano B., Moro A., Di Penta A., Reis S., Oostra B., and Bagni C. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112 (2003) 317-327
90. Iacoangeli A., Rozhdestvensky T.S., Dolzhanskaya N., Tournier B., Schutt J., Brosius J., Denman R.B., Khandjian E.W., Kindler S., and Tiedge H. On BC1 RNA and the fragile X mental retardation protein. Proc. Natl. Acad. Sci. U S A 105 (2008) 734-739
91. Darnell J.C., Fraser C.E., Mostovetsky O., Stefani G., Jones T.A., Eddy S.R., and Darnell R.B. Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev. 19 (2005) 903-918
92. Tang S.J., Meulemans D., Vazquez L., Colaco N., and Schuman E. A role for a rat homolog of staufen in the transport of RNA to neuronal dendrites. Neuron 32 (2001) 463-475
93. Kim Y.K., Furic L., Desgroseillers L., and Maquat L.E. Mammalian Staufen1 recruits Upf1 to specific mRNA 3′UTRs so as to elicit mRNA decay. Cell 120 (2005) 195-208
94. Barbee S.A., Estes P.S., Cziko A.M., Hillebrand J., Luedeman R.A., Coller J.M., Johnson N., Howlett I.C., Geng C., Ueda R., Brand A.H., Newbury S.F., Wilhelm J.E., Levine R.B., Nakamura A., Parker R., and Ramaswami M. Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies. Neuron 52 (2006) 997-1009
95. Kanai Y., Dohmae N., and Hirokawa N. Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 43 (2004) 513-525
96. Tretiakova A., Steplewski A., Johnson E.M., Khalili K., and Amini S. Regulation of myelin basic protein gene transcription by Sp1 and Puralpha: evidence for association of Sp1 and Puralpha in brain. J. Cell Physiol. 181 (1999) 160-168
97. Tretiakova A., Gallia G.L., Shcherbik N., Jameson B., Johnson E.M., Amini S., and Khalili K. Association of Puralpha with RNAs homologous to 7 SL determines its binding ability to the myelin basic protein promoter DNA sequence. J. Biol. Chem. 273 (1998) 22241-22247
98. Johnson E.M., Kinoshita Y., Weinreb D.B., Wortman M.J., Simon R., Khalili K., Winckler B., and Gordon J. Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J. Neurosci. Res. 83 (2006) 929-943
99. Ohashi S., Koike K., Omori A., Ichinose S., Ohara S., Kobayashi S., Sato T.A., and Anzai K. Identification of mRNA/protein (mRNP) complexes containing Puralpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor. J. Biol. Chem. 277 (2002) 37804-37810
100. Jin P., Duan R., Qurashi A., Qin Y., Tian D., Rosser T.C., Liu H., Feng Y., and Warren S.T. Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome. Neuron 55 (2007) 556-564
101. Chepenik L.G., Tretiakova A.P., Krachmarov C.P., Johnson E.M., and Khalili K. The single-stranded DNA binding protein, Pur-alpha, binds HIV-1 TAR RNA and activates HIV-1 transcription. Gene 210 (1998) 37-44
102. Tenenbaum S.A., Lager P.J., Carson C.C., and Keene J.D. Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays. Methods 26 (2002) 191-198
103. Ule J., Jensen K., Mele A., and Darnell R.B. CLIP: a method for identifying protein-RNA interaction sites in living cells. Methods 37 (2005) 376-386
104. Gallia G.L., Johnson E.M., and Khalili K. Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein. Nucleic. Acids Res. 28 (2000) 3197-3205
105. Okano H., Imai T., and Okabe M. Musashi: a translational regulator of cell fate. J. Cell Sci. 115 (2002) 1355-1359
106. Roegiers F., and Jan Y.N. Staufen: a common component of mRNA transport in oocytes and neurons?. Trends Cell Biol. 10 (2000) 220-224
107. Maurer-Stroh S., Dickens N.J., Hughes-Davies L., Kouzarides T., Eisenhaber F., and Ponting C.P. The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains. Trends Biochem. Sci. 28 (2003) 69-74